nature.com search

Loading Filters

Showing 1–19 of 19 results

Loading Filters

Amendments and Corrections | 19 September 2013
Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
- Alexander D. Douglas
- , Andrew R. Williams
- , Joseph J. Illingworth
- , Gathoni Kamuyu
- , Sumi Biswas
- , Anna L. Goodman
- , David H. Wyllie
- , Cécile Crosnier
- , Kazutoyo Miura
- , Gavin J. Wright
- , Carole A. Long
- , Faith H. Osier
- , Kevin Marsh
- , Alison V. Turner
- , Adrian V. S. Hill
- & Simon J. Draper
Nature Communications 4 , 1–1

Rights & permissionsfor article Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody . Opens in a new window.
Research | 28 July 2020 | Open
Evaluation and modeling of direct membrane-feeding assay with Plasmodium vivax to support development of transmission blocking vaccines
Scientific Reports 10 , 1–13

Rights & permissionsfor article Evaluation and modeling of direct membrane-feeding assay with Plasmodium vivax to support development of transmission blocking vaccines . Opens in a new window.
Research | 16 July 2020 | Open
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations
- Yvonne Azasi
- , Shannon K. Gallagher
- , Ababacar Diouf
- , Rebecca A. Dabbs
- , Jing Jin
- , Syed Yusuf Mian
- , David L. Narum
- , Carole A. Long
- , Deepak Gaur
- , Simon J. Draper
- , Michael P. Fay
- , Louis H. Miller
- & Kazutoyo Miura
Scientific Reports 10 , 1–12

Rights & permissionsfor article Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations . Opens in a new window.
Research | 5 April 2017 | Open
Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate
- Masayuki Morita
- , Eizo Takashima
- , Daisuke Ito
- , Kazutoyo Miura
- , Amporn Thongkukiatkul
- , Ababacar Diouf
- , Rick M. Fairhurst
- , Mahamadou Diakite
- , Carole A. Long
- , Motomi Torii
- & Takafumi Tsuboi
Scientific Reports 7 , 1–8

Rights & permissionsfor article Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate . Opens in a new window.
Research | 18 March 2020 | Open
Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment
- Wei-Chiao Huang
- , Bingbing Deng
- , Amal Seffouh
- , Joaquin Ortega
- , Carole A. Long
- , Ragavan V. Suresh
- , Xuedan He
- , Kazutoyo Miura
- , Shwu-Maan Lee
- , Yimin Wu
- & Jonathan F. Lovell
npj Vaccines 5 , 1–9

Rights & permissionsfor article Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment . Opens in a new window.
Research | 15 January 2020 | Open
A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system
Scientific Reports 10 , 1–14

Rights & permissionsfor article A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system . Opens in a new window.
Research | 24 September 2019 | Open
Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25
- Brandon McLeod
- , Kazutoyo Miura
- , Stephen W. Scally
- , Alexandre Bosch
- , Ngan Nguyen
- , Hanjun Shin
- , Dongkyoon Kim
- , Wayne Volkmuth
- , Sebastian Rämisch
- , Jessica A. Chichester
- , Stephen Streatfield
- , Colleen Woods
- , William R. Schief
- , Daniel Emerling
- , C. Richter King
- & Jean-Philippe Julien
Nature Communications 10 , 1–11

Rights & permissionsfor article Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25 . Opens in a new window.
Research | 8 July 2019 | Open
A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria
- Tarlan Mamedov
- , Kader Cicek
- , Kazutoyo Miura
- , Burcu Gulec
- , Ersin Akinci
- , Gunay Mammadova
- & Gulnara Hasanova
Scientific Reports 9 , 1–12

Rights & permissionsfor article A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria . Opens in a new window.
Research | 26 April 2019 | Open
A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates
- Alexander D. Douglas
- , G. Christian Baldeviano
- , Jing Jin
- , Kazutoyo Miura
- , Ababacar Diouf
- , Zenon A. Zenonos
- , Julio A. Ventocilla
- , Sarah E. Silk
- , Jennifer M. Marshall
- , Daniel G. W. Alanine
- , Chuan Wang
- , Nick J. Edwards
- , Karina P. Leiva
- , Luis A. Gomez-Puerta
- , Carmen M. Lucas
- , Gavin J. Wright
- , Carole A. Long
- , Joseph M. Royal
- & Simon J. Draper
Nature Communications 10 , 1–8

Rights & permissionsfor article A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates . Opens in a new window.
Research | 20 September 2018 | Open
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
- Frank Lennartz
- , Florian Brod
- , Rebecca Dabbs
- , Kazutoyo Miura
- , David Mekhaiel
- , Arianna Marini
- , Matthijs M. Jore
- , Max M. Søgaard
- , Thomas Jørgensen
- , Willem A. de Jongh
- , Robert W. Sauerwein
- , Carole A. Long
- , Sumi Biswas
- & Matthew K. Higgins
Nature Communications 9 , 1–11

Rights & permissionsfor article Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody . Opens in a new window.
Research | 26 October 2018 | Open
Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45
- Prasun Kundu
- , Anthony Semesi
- , Matthijs M. Jore
- , Merribeth J. Morin
- , Virginia L. Price
- , Alice Liang
- , Jingxing Li
- , Kazutoyo Miura
- , Robert W. Sauerwein
- , C. Richter King
- & Jean-Philippe Julien
Nature Communications 9 , 1–9

Rights & permissionsfor article Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45 . Opens in a new window.
Research | 8 October 2018
A malaria vaccine adjuvant based on recombinant antigen binding to liposomes
- Wei-Chiao Huang
- , Bingbing Deng
- , Cuiyan Lin
- , Kevin A. Carter
- , Jumin Geng
- , Aida Razi
- , Xuedan He
- , Upendra Chitgupi
- , Jasmin Federizon
- , Boyang Sun
- , Carole A. Long
- , Joaquin Ortega
- , Sheetij Dutta
- , C. Richter King
- , Kazutoyo Miura
- , Shwu-Maan Lee
- & Jonathan F. Lovell
Nature Nanotechnology 13 , 1174–1181

Rights & permissionsfor article A malaria vaccine adjuvant based on recombinant antigen binding to liposomes . Opens in a new window.
Research | 22 May 2017 | Open
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection
- Prakash Srinivasan
- , G. Christian Baldeviano
- , Kazutoyo Miura
- , Ababacar Diouf
- , Julio A. Ventocilla
- , Karina P. Leiva
- , Luis Lugo-Roman
- , Carmen Lucas
- , Sachy Orr-Gonzalez
- , Daming Zhu
- , Eileen Villasante
- , Lorraine Soisson
- , David L. Narum
- , Susan K. Pierce
- , Carole A. Long
- , Carter Diggs
- , Patrick E. Duffy
- , Andres G. Lescano
- & Louis H. Miller
npj Vaccines 2 , 1–10

Rights & permissionsfor article A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection . Opens in a new window.
Research | 16 November 2017 | Open
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
- Stephen W. Scally
- , Brandon McLeod
- , Alexandre Bosch
- , Kazutoyo Miura
- , Qi Liang
- , Sean Carroll
- , Sini Reponen
- , Ngan Nguyen
- , Eldar Giladi
- , Sebastian Rämisch
- , Vidadi Yusibov
- , Allan Bradley
- , Franck Lemiale
- , William R. Schief
- , Daniel Emerling
- , Paul Kellam
- , C. Richter King
- & Jean-Philippe Julien
Nature Communications 8 , 1–11

Rights & permissionsfor article Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25 . Opens in a new window.
Research | 19 June 2017 | Open
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines
- Darren B. Leneghan
- , Kazutoyo Miura
- , Iona J. Taylor
- , Yuanyuan Li
- , Jing Jin
- , Karl D. Brune
- , Martin F. Bachmann
- , Mark Howarth
- , Carole A. Long
- & Sumi Biswas
Scientific Reports 7 , 1–14

Rights & permissionsfor article Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines . Opens in a new window.
Research | 11 May 2017 | Open
The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens
Scientific Reports 7 , 1–12

Rights & permissionsfor article The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens . Opens in a new window.
Research | 8 January 2016 | Open
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology
- Yuanyuan Li
- , Darren B. Leneghan
- , Kazutoyo Miura
- , Daria Nikolaeva
- , Iona J. Brian
- , Matthew D. J. Dicks
- , Alex J. Fyfe
- , Sarah E. Zakutansky
- , Simone de Cassan
- , Carole A. Long
- , Simon J. Draper
- , Adrian V. S. Hill
- , Fergal Hill
- & Sumi Biswas
Scientific Reports 6 , 1–13

Rights & permissionsfor article Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology . Opens in a new window.
Research | 16 September 2015 | Open
Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria
- David Llewellyn
- , Kazutoyo Miura
- , Michael P. Fay
- , Andrew R. Williams
- , Linda M. Murungi
- , Jianguo Shi
- , Susanne H. Hodgson
- , Alexander D. Douglas
- , Faith H. Osier
- , Rick M. Fairhurst
- , Mahamadou Diakite
- , Richard J. Pleass
- , Carole A. Long
- & Simon J. Draper
Scientific Reports 5 , 1–14

Rights & permissionsfor article Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria . Opens in a new window.
Research | 20 December 2011
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
- Alexander D. Douglas
- , Andrew R. Williams
- , Joseph J. Illingworth
- , Gathoni Kamuyu
- , Sumi Biswas
- , Anna L. Goodman
- , David H. Wyllie
- , Cécile Crosnier
- , Kazutoyo Miura
- , Gavin J. Wright
- , Carole A. Long
- , Faith H. Osier
- , Kevin Marsh
- , Alison V. Turner
- , Adrian V.S. Hill
- & Simon J. Draper
Nature Communications 2 , 1–9

Rights & permissionsfor article The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody . Opens in a new window.

Refine your results by…

Filters

Filter By:

Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Evaluation and modeling of direct membrane-feeding assay with Plasmodium vivax to support development of transmission blocking vaccines

Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations

Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate

Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment

A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system

Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25

A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria

A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody

Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection

Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25

Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines

The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology

Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters